ijms-logo

Journal Browser

Journal Browser

Recent Progress in Nanomedicine for Cancer Therapy

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Nanoscience".

Deadline for manuscript submissions: 30 September 2025 | Viewed by 11

Special Issue Editor


E-Mail Website
Guest Editor
Department of Drug Discovery and Biomedical Sciences, College of Pharmacy, University of South Carolina, Columbia, SC, USA
Interests: biomaterials; targeted drug delivery; cancer and CNS diseases targeted nanomedicine

Special Issue Information

Dear Colleagues,

Nanomedicine is revolutionizing the landscape of cancer research and treatment by enabling highly targeted therapeutic and diagnostic strategies. Through the integration of nanotechnology with oncology, researchers are achieving enhanced precision in drug delivery, improved imaging modalities, and novel therapeutic approaches that hold great promise for overcoming resistance, minimizing systemic toxicity, and achieving greater patient outcomes.

This Special Issue is dedicated to the latest advances in Recent Progress in Nanomedicine for Cancer Therapy. We aim to showcase high-quality contributions that explore how nanotechnology-based approaches can be leveraged to better understand, diagnose, and treat malignant diseases. By gathering innovative research and comprehensive reviews from international experts in the field, this Special Issue will provide a valuable resource for the scientific and clinical oncology communities.

We welcome submissions of original research articles, as well as reviews, that provide novel insights into the design, characterization, and application of nanomaterials for cancer-related diagnostics and therapies. Studies focusing on translational research, preclinical development, or clinical evaluation of nanomedicine platforms are especially encouraged.

Topics of interest include, but are not limited to, the following:

  • Targeted nanocarriers for cancer drug delivery and controlled release;
  • Nanoparticle-mediated immunotherapy and gene therapy in oncology;
  • Theragnostic: integrated diagnostic and therapeutic nanoplatforms;
  • Nanotechnology in tumor imaging and real-time monitoring of therapy;
  • Tumor microenvironment-responsive nanodevices.

This Special Issue aims to foster collaboration and innovation at the intersection of nanotechnology and oncology. We look forward to your valuable contributions to advance the field and improve therapeutic outcomes for cancer patients.

Prof. Dr. Peisheng Xu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • nanomedicine
  • cancer-targeted therapy
  • theragnostic
  • nanodevice

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop